Researcher infects himself with hookworms (and tiny intestinal camera) to observe how the worms reduce allergic responses

Read More...

ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2®, the first therapeutic vaccine for patients with celiac disease

Read More...

US Food and Drug Administration (FDA) has granted fast track designation to Alvine Pharmaceuticals' ALV003 for the potential treatment of celiac disease

Read More...

The sourdough fermentation may enhance the recovery from intestinal inflammation of celiac patients at the early stage of the gluten-free diet (Source: European Journal of Nutrition)

Read More...

The Celiac Center at The University of Tennessee Medical Center in Knoxville, Tennessee

Learn More...